18 research outputs found
Pengaruh Waktu Pemeraman Terhadap Kekuatan Paving Block Pasca Pembakaran Menggunakan Material Tanah Dan Kapur Untuk Jalan Lingkungan
Infrastructure rapid development sometimes had negative impact, such as the use of impermeable
pavement layers which result the infiltration be hampered. By utilizing the paving block, it can
resolve o f infrastuture development problem. Known, paving block is composition of building
materials that made from the mixture of portland cement or hydraulic adhesives, water, and
agrregates with or without the other ingridient as defined in SNI 03-0691-19996. To find the
other alternatives then will do the assesment with the limestone and soil.
Soil samples were tested from Desa Karang Anyar, South Lampung. The composition of mixture
was used 6 %, 8 % and 10 %, with curing time during 7, 14 and 28 days, and the treatment with
or without combustion and then paving block were tested with compressive strength and water
absorption.
The research results obtained by the characteristics of the soil is a clay samples. The average
value of compressive strength was linearly proportional to the amount of lime composition. The
compressive strength during 28 days of curring time and without combustion was from 32,96
kg/cm2 to 10,87 kg/cm2, then the compressive strength with combustion was from 16,99 kg/cm2 to
56,91 kg/cm. Water absorption test value was inversely proportional to the amount of lime
composition. The water absorption was from 10,07% to 15,07%. The compressive strength
resulting over all still not include the specifications of paving block in SK - SNI 03-1996, also for
the compressive strength was 85 kg/cm2. The value of water absorption test were not include the
specifications of paving block SK SNI - 03 - 0691-1996 which ranges from 3 % - 10 %
Lymphovascular invasion status at transurethral resection of bladder tumors may predict subsequent poor response of T1 tumors to bacillus Calmette-Guérin
A murine model of ulcerative colitis: induced with sinusitis-derived superantigen and food allergen
BACKGROUND: The etiology of ulcerative colitis (UC) is to be understood. The basic pathological feature of UC is intestinal chronic inflammation. Superantigen, such as Staphylococcus enterotoxin B (SEB), is reported to compromise intestinal barrier function by increasing epithelial permeability and initiate inflammation in the intestinal mucosa. Inasmuch as anatomic position of the sinus, chronic sinusitis-derived SEB may follow the secretion and to be swallowed down to the gastrointestinal tract and induce lesions to the intestinal mucosa. METHODS: Sinus wash fluid (SWF, containing SEB) was collected from a group of patients with both chronic sinusitis (CS) and UC. A group of mice were sensitized to ovalbumin (OVA) in the presence of SWF. The sensitized mice were challenged with the specific antigen OVA. The inflammatory status of the colonic tissue was determined with histology, serology and electron microscopy. Using horseradish peroxidase (HRP) as a tracer, another group of mice was stimulated with SWF for 2 hours. The HRP activity was detected in the colonic tissue with enzymatic approaches and electron microscopy. RESULTS: Epithelial hyperpermeability in colonic epithelium was induced by stimulating with SWF. The HRP activity in the colonic mucosa was almost 11 times more in the SWF treated group (3.2 ± 0.6 μg/g tissue) than the control group (0.3 ± 0.1 μg/g tissue). Mice were sensitized using a mixture of SWF and OVA (serum OVA-specific IgE was detected with a highest titer as 1:64). Challenge with OVA induced extensive inflammation in the colonic mucosa by showing (1) marked degranulation in mast cells (MC, 46.3 ± 4.5%) and eosinophils (Eo, 55.7 ± 4.2%); (2) inflammatory cell infiltration (MC = 145.2 ± 11.4; Eo = 215.8 ± 12.5; mononuclear cell = 258.4 ± 15.3/mm(2 )tissue); (3) increased MPO activity (12.9 ± 3.2 U/g tissue) and inflammatory scores (1.8 ± 0.3); (4) mucosal surface ulcers; (5) edema in the lamina propria; (6) bacterial translocation and abscess formation in the subepithelial region. CONCLUSION: Introducing Sinusitis-derived SEB-containing SWF to the gastrointestinal tract compromised colonic mucosal barrier function increasing epithelial permeability to luminal macromolecular protein in mice. The SWF facilitated colonic mucosal sensitization to luminal antigen. Multiple challenging the sensitized colonic mucosa with specific antigen OVA induced inflammation, induced a condition similar to human ulcerative colitis
Patterns of patient withdrawal from BCG treatment for bladder cancer:a retrospective time interval analysis
Completeness and correctness of registration of renal pelvic and ureteral cancer in the Swedish Cancer Registry
High-grade non-muscle-invasive bladder cancer: Is re-resection necessary in all patients before intravesical bacillus Calmette–Guérin treatment?
How to combine the molecular profile with the clinicopathological profile of urothelial neoplastic lesions
Immunostimulatory CpG Oligonucleotides Reduce Tumor Burden after Intravesical Administration in an Orthotopic Murine Bladder Cancer Model
<it>MDM2 </it>SNP309 promoter polymorphism and <it>p53 </it>mutations in urinary bladder carcinoma stage T1
<p>Abstract</p> <p>Background</p> <p>Urinary bladder carcinoma stage T1 is an unpredictable disease that in some cases has a good prognosis with only local or no recurrence, but in others can appear as a more aggressive tumor with progression to more advanced stages. The aim here was to investigate stage T1 tumors regarding <it>MDM2</it> promoter SNP309 polymorphism, mutations in the <it>p53</it> gene, and expression of p53 and p16 measured by immunohistochemistry, and subsequently relate these changes to tumor recurrence and progression. We examined a cohort of patients with primary stage T1 urothelial carcinoma of the bladder and their tumors.</p> <p>Methods</p> <p>After re-evaluation of the original slides and exclusions, the study population comprised 141 patients, all with primary stage T1 urothelial carcinoma of the bladder. The hospital records were screened for clinical parameters and information concerning presence of histologically proven recurrence and progression. The paraffin-embedded tumor material was evaluated by immunohistochemistry. Any mutations found in the <it>p53</it> gene were studied by single-strand conformation analysis and Sanger sequencing. The <it>MDM2</it> SNP309 polymorphism was investigated by pyrosequencing. Multivariate analyses concerning association with prognosis were performed, and Kaplan-Meier analysis was conducted for a combination of changes and time to progression.</p> <p>Results</p> <p>Of the 141 patients, 82 had at least one <it>MDM2</it> SNP309 G allele, and 53 had a mutation in the <it>p53</it> gene, but neither of those anomalies was associated with a worse prognosis. A mutation in the <it>p53</it> gene was associated with immunohistochemically visualized p53 protein expression at a cut-off value of 50%. In the group with <it>p53</it> mutation Kaplan-Meier analysis showed higher rate of progression and shorter time to progression in patients with immunohistochemically abnormal p16 expression compared to them with normal p16 expression (p = 0.038).</p> <p>Conclusions</p> <p><it>MDM2</it> SNP309 promoter polymorphism and mutations in <it>p53</it> were not associated with worse prognosis in this cohort of patients with primary stage T1 urinary bladder carcinoma. However, patients with abnormal p16 expression and a mutated <it>p53</it> gene had a higher rate of and a shorter time to progression, and <it>p53</it> gene mutation was associated with an abnormal immunohistochemistry for p53 at a cut-off of 50%.</p